Allergan CEO resigns from Edwards Lifesciences' board
Oct 3 (Reuters) - Edwards Lifesciences Corp said David Pyott resigned from the medical device maker's board to devote more time to his role as chairman and CEO of Allergan Inc .
The resignation of Pyott, who joined Edwards' board in 2000, is effective immediately, the company said in a statement.
Allergan is fighting a $53.7-billion hostile bid from Canada's Valeant Pharmaceuticals International Inc and billionaire William Ackman's Pershing Square.
Edwards Lifesciences shares closed at $106.18 Friday on the New York Stock Exchange. (Reporting by Shailesh Kuber in Bangalore; Editing by Anil D'Silva)
© Thomson Reuters 2017 All rights reserved.